MedTrace Logo

Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

NCT01316419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2089

Last updated 2015-09-21

Study results available
· View outcomes & findings →

Summary

This observational study is designed to evaluate the effects of Twynsta tablets with life style modifications on blood pressure, quality of life, and other risk factors in Korean patients with hypertension in a routine clinical practice setting.

Conditions

Interventions

DRUG

Telmisartan

Telmisartan 40mg or 80mg

DRUG

amlodipine

amlodipine 5mg or 10mg

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01316419 on ClinicalTrials.gov